// App-Quantinova.ai

TCT-37 : Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in Patients with De Novo Coronary Artery Disease

Researchers

Presenter

  • Yoshinobu Onuma

Principal Investigators

  • Koen Nieman

  • Mark Webster

  • Leif Thuesen

  • Dariusz Dudek

  • John Ormiston

  • Patrick W Serruys

Medical Centers

  • The University Hospital, Krakow, Poland

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Thoraxcenter, Rotterdam, Netherlands

  • Professor, University of Auckland Medical School, Auckland, New Zealand

  • Auckland City Hospital, Auckland, New Zealand

  • Department of Urology, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark

Locations

  • Poland

  • Denmark

  • New Zealand

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Hodgkin's Lymphoma

  • Angina

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved